These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37128639)

  • 1. Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease.
    Fan P; Zeng L; Ding Y; Kofler J; Silverstein J; Krivinko J; Sweet RA; Wang L
    CPT Pharmacometrics Syst Pharmacol; 2023 Aug; 12(8):1119-1131. PubMed ID: 37128639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Antidepressants and Antipsychotics as A Novel Treatment Option for Psychosis in Alzheimer's Disease.
    Fan P; Zeng L; Ding Y; Kofler J; Silverstein J; Krivinko J; Sweet RA; Wang L
    medRxiv; 2023 Jan; ():. PubMed ID: 36747620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy difference of antipsychotics in Alzheimer's disease and schizophrenia: explained with network efficiency and pathway analysis methods.
    Fan P; Kofler J; Ding Y; Marks M; Sweet RA; Wang L
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36151774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
    Farahani A; Correll CU
    J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.
    Caraci F; Santagati M; Caruso G; Cannavò D; Leggio GM; Salomone S; Drago F
    F1000Res; 2020; 9():. PubMed ID: 32695312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.
    Madhusoodanan S; Shah P
    Clin Interv Aging; 2008; 3(3):491-501. PubMed ID: 18982919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
    Kirbach S; Simpson K; Nietert PJ; Mintzer J
    Clin Drug Investig; 2008; 28(5):291-303. PubMed ID: 18407715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to manage depression and psychosis in Alzheimer's disease.
    Tueth MJ
    Geriatrics; 1995 Jan; 50(1):43-6, 49. PubMed ID: 7821828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service.
    Glass OM; Hermida AP; Hershenberg R; Schwartz AC
    Curr Psychiatry Rep; 2020 Apr; 22(5):21. PubMed ID: 32285305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in Alzheimer's Disease.
    Ballard C; Kales HC; Lyketsos C; Aarsland D; Creese B; Mills R; Williams H; Sweet RA
    Curr Neurol Neurosci Rep; 2020 Oct; 20(12):57. PubMed ID: 33048274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fall and Fracture Risk in Nursing Home Residents With Moderate-to-Severe Behavioral Symptoms of Alzheimer's Disease and Related Dementias Initiating Antidepressants or Antipsychotics.
    Wei YJ; Simoni-Wastila L; Lucas JA; Brandt N
    J Gerontol A Biol Sci Med Sci; 2017 May; 72(5):695-702. PubMed ID: 27247274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Systems Pharmacology-Based Mechanism Study on the Beneficial Effects of Vitamin D against Psychosis in Alzheimer's Disease.
    Fan P; Qi X; Sweet RA; Wang L
    Sci Rep; 2020 Apr; 10(1):6136. PubMed ID: 32273551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.